Cumberland Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Cumberland Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Tennessee
- Headquarters city
- Nashville
- Headquarters state / province
- Tennessee
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CPIX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001087294
- EIN
- 62-1765329
Board of directors
-
A. J. Kazimi · Director · Chairman and CEOSince 2023
-
Caroline Young · DirectorSince 2023
-
James Jones · DirectorSince 2023
-
Joey A. Jacobs · DirectorSince 2023
-
Joseph C. Galante · DirectorSince 2023
-
Kenneth Krogulski · DirectorSince 2023
-
Martin S. Brown Jr. · DirectorSince 2023
Chief executives
A. J. Kazimi
· Chairman and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Martin S. Brown Jr. Director | Grant or award | +1,800 | $2.80 | $5,040 |
| Mar 18, 2026 | Joseph C. Galante Director | Grant or award | +1,800 | $2.80 | $5,040 |
| Mar 18, 2026 | James Jones Director | Grant or award | +1,800 | $2.80 | $5,040 |
| Mar 18, 2026 | Kenneth Krogulski Director | Grant or award | +1,800 | $2.80 | $5,040 |
| Mar 18, 2026 | Caroline Young Director | Grant or award | +1,800 | $2.80 | $5,040 |
| Mar 18, 2026 | Kenneth Krogulski Director | Grant or award | +4,000 | $2.80 | $11,200 |
| Mar 16, 2026 | A. J. Kazimi Director, Officer (Chairman and CEO), 10% owner | Shares withheld for tax | −5,845 | $3.06 | $17,886 |
| Dec 31, 2025 | Caroline Young Director | Small acquisition | +5 | $3.91 | $20 |
| Dec 31, 2025 | James Jones Director | Small acquisition | +7 | $3.91 | $27 |
| Dec 31, 2025 | A. J. Kazimi Director, Officer (Chairman and CEO), 10% owner | Small acquisition | +7 | $3.91 | $27 |
| Dec 31, 2025 | Kenneth Krogulski Director | Small acquisition | +62 | $3.91 | $242 |
| Dec 30, 2025 | Caroline Young Director | Small acquisition | +2 | $3.94 | $8 |
| Dec 30, 2025 | James Jones Director | Small acquisition | +8 | $3.94 | $32 |
| Dec 30, 2025 | A. J. Kazimi Director, Officer (Chairman and CEO), 10% owner | Small acquisition | +8 | $3.94 | $32 |
| Dec 30, 2025 | Kenneth Krogulski Director | Small acquisition | +54 | $3.94 | $213 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.